Detalhe da pesquisa
1.
Overall survival of children and adolescents with mature B cell non-Hodgkin lymphoma who had refractory or relapsed disease during or after treatment with FAB/LMB 96: A report from the FAB/LMB 96 study group.
Br J Haematol
; 182(6): 859-869, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29984828
2.
Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapy.
Blood
; 121(2): 278-85, 2013 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23149845
3.
Excellent outcomes in children and adolescents with CNS+ Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1.
Br J Haematol
; 185(2): 374-377, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30117142
4.
Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: a Children's Oncology Group report.
Br J Haematol
; 162(5): 678-83, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23802659
5.
BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group.
Blood
; 117(9): 2596-603, 2011 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-21079154
6.
An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children's Oncology Group study CCG-5961.
Br J Haematol
; 148(4): 600-10, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19895612
7.
Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: final results of Children's Cancer Group Study 5941.
Pediatr Blood Cancer
; 52(3): 335-9, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18985718
8.
Shortened intensified multi-agent chemotherapy and non-cross resistant maintenance therapy for advanced lymphoblastic lymphoma in children and adolescents: report from the Children's Oncology Group.
Br J Haematol
; 143(2): 261-7, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18759768
9.
Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study.
Br J Haematol
; 141(6): 840-7, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18371107
10.
A phase I study of 90yttrium-ibritumomab-tiuxetan in children and adolescents with relapsed/refractory CD20-positive non-Hodgkin's lymphoma: a Children's Oncology Group study.
Clin Cancer Res
; 13(18 Pt 2): 5652s-5660s, 2007 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17875803
11.
A dose substitution of anthracycline intensity with dose-dense rituximab in children and adolescents with good-risk mature B-cell lymphoma.
Leukemia
; 35(10): 2994-2997, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33941850
12.
Non-Hodgkin's lymphoma arising in bone in children and adolescents is associated with an excellent outcome: a Children's Cancer Group report.
J Clin Oncol
; 20(9): 2293-301, 2002 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11981000
13.
Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead.
J Clin Oncol
; 33(27): 2963-74, 2015 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26304908
14.
B large-cell lymphoma in children and adolescents.
Cancer Treat Rev
; 29(2): 91-8, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12670451
15.
Advanced stage, increased lactate dehydrogenase, and primary site, but not adolescent age (≥ 15 years), are associated with an increased risk of treatment failure in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB LMB 96 study.
J Clin Oncol
; 30(4): 387-93, 2012 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22215753
16.
Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients.
Blood
; 109(7): 2773-80, 2007 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17132719
17.
Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents.
Blood
; 109(7): 2736-43, 2007 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17138821
18.
Mature B-cell lymphoma in children and adolescents: International group pathologist consensus correlates with histology technical quality.
J Pediatr Hematol Oncol
; 28(9): 568-74, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17006262
19.
Childhood and adolescent non-Hodgkin lymphoma: new insights in biology and critical challenges for the future.
Pediatr Blood Cancer
; 45(6): 753-69, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-15929129
20.
Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experience.
Br J Haematol
; 120(4): 660-70, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12588354